IO Combinations in Early or Intermediate-Stage HCC: Current Evidence and Ongoing Trials

Download this slideset from Peter R. Galle, MD, PhD, to see the latest data on immunotherapy treatment options for patients with early or intermediate-stage hepatocellular carcinoma.
Peter R. Galle, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 992 KB
Released: October 14, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Download this slideset from Clinical Care Options, to see the latest data on immunotherapy treatment options for patients with hepatocellular carcinoma.

Bruno Sangro, MD, PhD Released: October 14, 2020

Download this slideset from Clinical Care Options, to see the latest data on first-line immunotherapy treatment options for patients with advanced HCC.

Ghassan K. Abou-Alfa, MD, MBA Released: October 14, 2020

Downloadable slideset on best practices for biomarker testing in the treatment of patients with advanced NSCLC, from Clinical Care Options (CCO)

Lauren L. Ritterhouse, MD Released: October 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue